Pacira BioSciences, Inc. PCRX Deferred Tax Assets
Deferred Tax Assets at other companies
Other financials
Where this comes from
Reported directly by Pacira BioSciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DeferredIncomeTaxAssetsNet.
The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacira BioSciences, Inc.'s deferred tax assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacira BioSciences, Inc.'s deferred tax assets?
- Pacira BioSciences, Inc. (PCRX) reported deferred tax assets of $122.12M in Q1 2026.
- How has Pacira BioSciences, Inc.'s deferred tax assets changed year-over-year?
- Pacira BioSciences, Inc.'s deferred tax assets decreased by 5.3% year-over-year, from $129.01M to $122.12M.
- What is the long-term trend for Pacira BioSciences, Inc.'s deferred tax assets?
- Over 5 years (2020 to 2025), Pacira BioSciences, Inc.'s deferred tax assets has grown at a 3.1% compound annual growth rate (CAGR), from $106.16M to $123.85M.
- What does deferred tax assets mean?
- Represents future tax benefits arising from temporary differences between the book value of assets/liabilities and their tax basis, or from carry-forward tax losses. These assets are realized when the firm generates sufficient taxable income to offset these differences. It serves as an indicator of future tax savings potential.